Your session is about to expire
← Back to Search
Individualized Metabolic Therapy for Gestational Diabetes (MATCh-GDM Trial)
MATCh-GDM Trial Summary
This trial will investigate whether an individualized treatment approach for gestational diabetes, based on each woman's specific mechanism for the condition, is more effective than the current standard approach.
- Gestational Diabetes
MATCh-GDM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MATCh-GDM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your liver function test results are more than two times the normal range.You have diabetes before becoming pregnant.You have gestational diabetes but have not completed a 3-hour oral glucose tolerance test.You are allergic to glyburide, metformin, or sulfa.You have had heart failure or a heart attack in the past.Women who are more than 24 weeks pregnant and have a planned 3-hour oral glucose test are not eligible.Your kidney function is not normal, with a specific blood test result showing higher than 1.2 mg/dL of creatinine.Unborn baby has a medical condition.You haven't taken any steroids that are not inhaled in the past 7 days.You have a history of needing oxygen therapy or daily treatment for severe lung problems.
- Group 1: Individualized Treatment
- Group 2: Usual Care
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is recruitment for this study still open?
"Affirmative, the clinical trial is actively recruiting according to details hosted on clinicaltrials.gov. This particular investigation was initially posted in February 28th 2018 and its information has been updated most recently on April 4th 2022. A total of 60 patients have to be recruited from a single medical centre for this study."
What research has been conducted to identify the efficacy of personalized therapies?
"Currently, 242 research projects are underway for Individualized Treatment with 57 trials in their final phase. Tustin, California is the primary location of these studies; however, there are 2346 medical centres performing clinical trials related to this treatment method."
Has the FDA sanctioned Individualized Treatment?
"Our team assigned Individualized Treatment a score of 3, indicating that the treatment has already gone through multiple rounds of trials and is officially approved."
Does this trial accept those in the senior demographic?
"This medical research is recruiting individuals aged between 18 and 45 years old."
Who is eligible to join this medical experiment?
"This medical experiment seeks 60 participants suffering from diabetes, who are pregnant and between 18-45 years of age. Crucially, candidates ought to be beyond 24 weeks gestation with plans for a 3 hour oral glucose tolerance test."
Are there any limits on the number of participants accepted in this empirical research?
"Affirmative. Data hosted on clinicaltrials.gov conclusively declares that this medical investigation, which was initially published on February 28th 2018, is currently recruiting patients. Sixty people need to be enlisted from 1 site in total."
What conditions typically benefit from a personalized form of care?
"Individualized Treatment is a popular option for type 2 diabetes mellitus patients, but can also be leveraged to help manage glycemic control, exercise-induced issues and gestational diabetes mellitus (GDM)."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger